{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:48:23Z","timestamp":1791557303893,"version":"4.3.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":1033,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1469-0691.2011.03741.x","type":"journal-article","created":{"date-parts":[[2011,11,28]],"date-time":"2011-11-28T22:49:57Z","timestamp":1322520597000},"page":"126-133","source":"Crossref","is-referenced-by-count":46,"title":["Immunotherapy of Cryptococcus infections"],"prefix":"10.1016","volume":"18","author":[{"given":"C.","family":"Antachopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03741.x_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1513\/pats.200907-063AL","article-title":"Cryptococcus","volume":"7","author":"Li","year":"2010","journal-title":"Proc Am Thorac Soc"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-007-6142-8","article-title":"Non\u2010neoformans cryptococcal infections: a systematic review","volume":"35","author":"Khawcharoenporn","year":"2007","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3201\/eid1602.090900","article-title":"Epidemiology ofCryptococcus gattii, British Columbia, Canada, 1999\u20132007","volume":"16","author":"Galanis","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11908-011-0181-0","article-title":"The outbreak ofCryptococcus gattii in Western North America: epidemiology and clinical issues","volume":"13","author":"Byrnes","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/JCM.01985-10","article-title":"Most cases of cryptococcal meningitis in HIV\u2010uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism\u2010defined cluster ofCryptococcus neoformans var. grubii VN1","volume":"49","author":"Day","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/JCM.01277-10","article-title":"Analyses of pediatric isolates ofCryptococcus neoformans from South Africa","volume":"49","author":"Miglia","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib8","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","article-title":"Long\u2010term outcome of AIDS\u2010associated cryptococcosis in the era of combination antiretroviral therapy","volume":"20","author":"Lortholary","year":"2006","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-2164(09)01204-0","article-title":"The capsule of the fungal pathogenCryptococcus neoformans","volume":"68","author":"Zaragoza","year":"2009","journal-title":"Adv Appl Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal interactions with the host immune system","volume":"9","author":"Voelz","year":"2010","journal-title":"Eukaryot Cell"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3181\/00379727-144-37580","article-title":"The role of late complement components and the alternate complement pathway in experimental cryptococcosis","volume":"144","author":"Diamond","year":"1973","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib13","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/IAI.59.9.3101-3110.1991","article-title":"Early events in initiation of alternative complement pathway activation by the capsule ofCryptococcus neoformans","volume":"59","author":"Kozel","year":"1991","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib14","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.4049\/jimmunol.112.6.2260","article-title":"The role of the classical and alternate complement pathways in host defenses againstCryptococcus neoformans infection","volume":"112","author":"Diamond","year":"1974","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib15","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.166.7.4620","article-title":"Toll\u2010like receptor\u00a04 mediates intracellular signaling without TNF\u2010alpha release in response toCryptococcus neoformans polysaccharide capsule","volume":"166","author":"Shoham","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/IAI.73.2.820-827.2005","article-title":"Mannoproteins fromCryptococcus neoformans promote dendritic cell maturation and activation","volume":"73","author":"Pietrella","year":"2005","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS\u2014100\u00a0years after the discovery ofCryptococcus neoformans","volume":"8","author":"Mitchell","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib18","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1128\/IAI.70.11.5972-5981.2002","article-title":"Primary dendritic cells phagocytoseCryptococcus neoformans via mannose receptors and Fcgamma receptor\u00a0II for presentation to T\u00a0lymphocytes","volume":"70","author":"Syme","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/IAI.73.1.592-598.2005","article-title":"Opsonic requirements for dendritic cell\u2010mediated responses toCryptococcus neoformans","volume":"73","author":"Kelly","year":"2005","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib20","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.176.5.3053","article-title":"Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells","volume":"176","author":"Mansour","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1128\/IAI.67.2.885-890.1999","article-title":"Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages","volume":"67","author":"Levitz","year":"1999","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib22","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/IAI.68.7.4225-4237.2000","article-title":"Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection","volume":"68","author":"Feldmesser","year":"2000","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2172-8-16","article-title":"Cell\u2010to\u2010cell spread and massive vacuole formation afterCryptococcus neoformans infection of murine macrophages","volume":"8","author":"Alvarez","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1128\/EC.3.5.1067-1075.2004","article-title":"Role of phagocytosis in the virulence ofCryptococcus neoformans","volume":"3","author":"Del Poeta","year":"2004","journal-title":"Eukaryot Cell"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib25","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cub.2006.09.061","article-title":"Phagosome extrusion and host\u2010cell survival afterCryptococcus neoformans phagocytosis by macrophages","volume":"16","author":"Alvarez","year":"2006","journal-title":"Curr Biol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib26","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.cub.2006.09.032","article-title":"Expulsion of live pathogenic yeast by macrophages","volume":"16","author":"Ma","year":"2006","journal-title":"Curr Biol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib27","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.4049\/jimmunol.156.10.3836","article-title":"Oxidative killing ofCryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates","volume":"156","author":"Chaturvedi","year":"1996","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/IAI.59.1.24-28.1991","article-title":"Killing ofCryptococcus neoformans strains by human neutrophils and monocytes","volume":"59","author":"Miller","year":"1991","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib29","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1128\/IAI.68.11.6257-6264.2000","article-title":"Human neutrophil\u2010mediated nonoxidative antifungal activity againstCryptococcus neoformans","volume":"68","author":"Mambula","year":"2000","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V76.11.2169.2169","article-title":"Antimicrobial polypeptides of human neutrophils","volume":"76","author":"Lehrer","year":"1990","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib31","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1128\/IAI.60.8.3446-3447.1992","article-title":"Mouse neutrophils lack defensins","volume":"60","author":"Eisenhauer","year":"1992","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib32","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/IAI.62.7.2857-2864.1994","article-title":"Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive withCryptococcus neoformans glucuronoxylomannan","volume":"62","author":"Houpt","year":"1994","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/315102","article-title":"Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus\u2010infected persons with and withoutCryptococcus neoformans meningitis","volume":"180","author":"Fleuridor","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.181.1.405","article-title":"Protective and nonprotective monoclonal antibodies toCryptococcus neoformans originating from one B\u00a0cell","volume":"181","author":"Mukherjee","year":"1995","journal-title":"J Exp Med"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib35","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1128\/IAI.70.6.2812-2819.2002","article-title":"Fc\u2010dependent and Fc\u2010independent opsonization ofCryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity","volume":"70","author":"Netski","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(02)00328-X","article-title":"CR3 (CD11b\/CD18) and CR4 (CD11c\/CD18) are involved in complement\u2010independent antibody\u2010mediated phagocytosis ofCryptococcus neoformans","volume":"16","author":"Taborda","year":"2002","journal-title":"Immunity"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/IAI.62.1.194-202.1994","article-title":"Direct activity of human T\u00a0lymphocytes and natural killer cells againstCryptococcus neoformans","volume":"62","author":"Levitz","year":"1994","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib38","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1182\/blood-2006-03-009720","article-title":"Cytotoxic CD4+ T\u00a0cells use granulysin to killCryptococcus neoformans, and activation of this pathway is defective in HIV patients","volume":"109","author":"Zheng","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib39","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.165.12.7102","article-title":"Granulysin, a T\u00a0cell product, kills bacteria by altering membrane permeability","volume":"165","author":"Ernst","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin\u2010mediated target\u2010cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib41","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4049\/jimmunol.142.9.3219","article-title":"Fungicidal activity of IFN\u2010gamma\u2010activated macrophages. Extracellular killing ofCryptococcus neoformans","volume":"142","author":"Flesch","year":"1989","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1348-0421.1995.tb02180.x","article-title":"T\u00a0cell\u2010dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat\u2010killedCryptococcus neoformans: involvement of IFN\u2010gamma and its protective effect against cryptococcal infection","volume":"39","author":"Kawakami","year":"1995","journal-title":"Microbiol Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib43","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1128\/IAI.00176-07","article-title":"Modulation of the pulmonary type\u00a02 T\u2010cell response toCryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha\u2010expressing adenoviral vector","volume":"75","author":"Milam","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib44","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4049\/jimmunol.176.2.1098","article-title":"IL\u201023 enhances the inflammatory cell response inCryptococcus neoformans infection and induces a cytokine pattern distinct from IL\u201012","volume":"176","author":"Kleinschek","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1165\/rcmb.2003-0156OC","article-title":"Role of interleukin\u20104 in resistance toCryptococcus neoformans infection","volume":"30","author":"Blackstock","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib46","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.179.8.5367","article-title":"IL\u201013 induces disease\u2010promoting type\u00a02 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice withCryptococcus neoformans","volume":"179","author":"Muller","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib47","first-page":"137","article-title":"Regulation by innate immune T\u00a0lymphocytes in the host defense against pulmonary infection withCryptococcus neoformans","volume":"57","author":"Kawakami","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2249.1996.14723.x","article-title":"IL\u201012 protects mice against pulmonary and disseminated infection caused byCryptococcus neoformans","volume":"104","author":"Kawakami","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/AAC.38.3.460","article-title":"Cytokine treatment of central nervous system infection: efficacy of interleukin\u201012 alone and synergy with conventional antifungal therapy in experimental cryptococcosis","volume":"38","author":"Clemons","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib50","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/IAI.66.10.4994-5000.1998","article-title":"Interleukin\u201012 is essential for a protective Th1 response in mice infected withCryptococcus neoformans","volume":"66","author":"Decken","year":"1998","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib51","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.4049\/jimmunol.159.11.5528","article-title":"IL\u201018 protects mice against pulmonary and disseminated infection withCryptococcus neoformans by inducing IFN\u2010gamma production","volume":"159","author":"Kawakami","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib52","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1128\/IAI.65.9.3594-3599.1997","article-title":"Interleukin\u201012 (IL\u201012) and IL\u201018 synergistically induce the fungicidal activity of murine peritoneal exudate cells againstCryptococcus neoformans through production of gamma interferon by natural killer cells","volume":"65","author":"Zhang","year":"1997","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib53","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<643::AID-IMMU643>3.0.CO;2-E","article-title":"Combined effects of IL\u201012 and IL\u201018 on the clinical course and local cytokine production in murine pulmonary infection withCryptococcus neoformans","volume":"29","author":"Qureshi","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib54","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/170.5.1331","article-title":"In\u00a0vivo activity of interferon\u2010gamma in combination with amphotericin\u00a0B in the treatment of experimental cryptococcosis","volume":"170","author":"Joly","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib55","first-page":"123","article-title":"Contribution of interferon\u2010gamma in protecting mice during pulmonary and disseminated infection withCryptococcus neoformans","volume":"13","author":"Kawakami","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib56","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/AAC.45.3.686-689.2001","article-title":"Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice","volume":"45","author":"Clemons","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jac\/46.3.437","article-title":"Enhancement of antifungal chemotherapy by interferon\u2010gamma in experimental systemic cryptococcosis","volume":"46","author":"Lutz","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib58","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon\u2010producingCryptococcus neoformans strain","volume":"75","author":"Wormley","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib59","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/IAI.58.5.1201-1209.1990","article-title":"Growth inhibition ofCryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines","volume":"58","author":"Levitz","year":"1990","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib60","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1165\/ajrcmb.15.6.8969264","article-title":"Interferon\u2010gamma reduces the capacity of human alveolar macrophages to inhibit growth ofCryptococcus neoformans in\u00a0vitro","volume":"15","author":"Reardon","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/cimm.1999.1460","article-title":"Role of TNF\u2010alpha in the induction of fungicidal activity of mouse peritoneal exudate cells againstCryptococcus neoformans by IL\u201012 and IL\u201018","volume":"193","author":"Kawakami","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib62","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/eji.1830220617","article-title":"Cytokine enhancement of complement\u2010dependent phagocytosis by macrophages: synergy of tumor necrosis factor\u2010alpha and granulocyte\u2013macrophage colony\u2010stimulating factor for phagocytosis ofCryptococcus neoformans","volume":"22","author":"Collins","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib63","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/IAI.74.4.2161-2168.2006","article-title":"Immunomodulation with CD40 stimulation and interleukin\u20102 protects mice from disseminated cryptococcosis","volume":"74","author":"Zhou","year":"2006","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib64","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.4049\/jimmunol.178.9.5753","article-title":"Protection from direct cerebralCryptococcus infection by interferon\u2010gamma\u2010dependent activation of microglial cells","volume":"178","author":"Zhou","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib65","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/IAI.55.3.742-748.1987","article-title":"Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive withCryptococcus neoformans capsular polysaccharide","volume":"55","author":"Dromer","year":"1987","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib66","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/IAI.70.5.2598-2604.2002","article-title":"Immunoglobulin\u00a0G monoclonal antibodies toCryptococcus neoformans protect mice deficient in complement component C3","volume":"70","author":"Shapiro","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib67","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1369-5274(02)00337-5","article-title":"Induced humoral immunity and vaccination against major human fungal pathogens","volume":"5","author":"Casadevall","year":"2002","journal-title":"Curr Opin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib68","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1128\/IAI.68.12.7049-7060.2000","article-title":"Human antibodies against a purified glucosylceramide fromCryptococcus neoformans inhibit cell budding and fungal growth","volume":"68","author":"Rodrigues","year":"2000","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib69","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1128\/CVI.00202-07","article-title":"Monoclonal antibody to fungal glucosylceramide protects mice against lethalCryptococcus neoformans infection","volume":"14","author":"Rodrigues","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib70","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/IAI.69.5.3410-3412.2001","article-title":"Passive immunization with melanin\u2010binding monoclonal antibodies prolongs survival of mice with lethalCryptococcus neoformans infection","volume":"69","author":"Rosas","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib71","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti\u2010beta\u2010glucan monoclonal antibody inhibits growth and capsule formation ofCryptococcus neoformans in\u00a0vitro and exerts therapeutic, anticryptococcal activity in\u00a0vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib72","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.166.3.2100","article-title":"Immunoglobulin\u00a0M efficacy againstCryptococcus neoformans: mechanism, dose dependence, and prozone\u2010like effects in passive protection experiments","volume":"166","author":"Taborda","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib73","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1128\/IAI.69.10.6445-6455.2001","article-title":"Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice againstCryptococcus neoformans","volume":"69","author":"Beenhouwer","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib74","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/IAI.70.3.1571-1580.2002","article-title":"Antibody\u2010mediated protection in murineCryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses","volume":"70","author":"Feldmesser","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib75","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1128\/IAI.73.2.1141-1150.2005","article-title":"Antibody\u2010mediated protection againstCryptococcus neoformans pulmonary infection is dependent on B\u00a0cells","volume":"73","author":"Rivera","year":"2005","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(06)91001-3","article-title":"A reappraisal of humoral immunity based on mechanisms of antibody\u2010mediated protection against intracellular pathogens","volume":"91","author":"Casadevall","year":"2006","journal-title":"Adv Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib77","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.4049\/jimmunol.170.7.3621","article-title":"More is not necessarily better: prozone\u2010like effects in passive immunization with IgG","volume":"170","author":"Taborda","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib78","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/IAI.01161-06","article-title":"Human immunoglobulin\u00a0G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice againstCryptococcus neoformans infection","volume":"75","author":"Beenhouwer","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib79","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.4049\/jimmunol.154.4.1810","article-title":"Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody toCryptococcus neoformans into a protective antibody","volume":"154","author":"Yuan","year":"1995","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib80","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/IAI.66.3.1057-1062.1998","article-title":"Isotype switching increases efficacy of antibody protection againstCryptococcus neoformans infection in mice","volume":"66","author":"Yuan","year":"1998","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib81","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1073\/pnas.94.6.2483","article-title":"T\u00a0cells cooperate with passive antibody to modifyCryptococcus neoformans infection in mice","volume":"94","author":"Yuan","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib82","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.4049\/jimmunol.168.7.3419","article-title":"Antibody efficacy in murine pulmonaryCryptococcus neoformans infection: a role for nitric oxide","volume":"168","author":"Rivera","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib83","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/515688","article-title":"A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis","volume":"178","author":"Fleuridor","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib84","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/IAI.55.3.749-752.1987","article-title":"Protection of mice against experimental cryptococcosis by anti\u2010Cryptococcus neoformans monoclonal antibody","volume":"55","author":"Dromer","year":"1987","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib85","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/IAI.60.11.4534-4541.1992","article-title":"Protective murine monoclonal antibodies toCryptococcus neoformans","volume":"60","author":"Mukherjee","year":"1992","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib86","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/IAI.58.6.1919-1923.1990","article-title":"Passive immunization againstCryptococcus neoformans with an isotype\u2010switch family of monoclonal antibodies reactive with cryptococcal polysaccharide","volume":"58","author":"Sanford","year":"1990","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib87","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","article-title":"Characterization of a murine monoclonal antibody toCryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies","volume":"42","author":"Casadevall","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib88","doi-asserted-by":"crossref","first-page":"10942","DOI":"10.1073\/pnas.1731272100","article-title":"Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection","volume":"100","author":"Dadachova","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib89","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/503369","article-title":"Interaction of radiolabeled antibodies with fungal cells and components of the immune system in\u00a0vitro and during radioimmunotherapy for experimental fungal infection","volume":"193","author":"Dadachova","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib90","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.48.3.1004-1006.2004","article-title":"Evaluation of acute hematologic and long\u2010term pulmonary toxicities of radioimmunotherapy ofCryptococcus neoformans infection in murine models","volume":"48","author":"Dadachova","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib91","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/AAC.01334-08","article-title":"Radioimmunotherapy is effective against high\u2010inoculumCryptococcus neoformans infection in mice and does not select for radiation\u2010resistant cryptococcal cells","volume":"53","author":"Bryan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib92","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/654813","article-title":"Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection","volume":"202","author":"Bryan","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib93","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.174.3.1746","article-title":"IFN\u2010gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis","volume":"174","author":"Siddiqui","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib94","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.jinf.2006.10.002","article-title":"Immune dysfunction in HIV\u2010seronegative,Cryptococcus gattii meningitis","volume":"54","author":"Brouwer","year":"2007","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib95","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1086\/317937","article-title":"Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus","volume":"183","author":"Lortholary","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib96","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon\u2010gamma\u00a01b as adjunctive therapy for AIDS\u2010related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib97","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/425121","article-title":"Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon\u2010gamma therapy","volume":"39","author":"Netea","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib98","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase\u00a0I evaluation of the safety and pharmacokinetics of murine\u2010derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib99","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.mib.2006.08.004","article-title":"Immunomodulators as an antimicrobial tool","volume":"9","author":"Pirofski","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03741.x_bib101","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00164-10","article-title":"Robust stimulation of humoral and cellular immune responses following vaccination with antigen\u2010loaded beta\u2010glucan particles","volume":"1","author":"Huang","year":"2010","journal-title":"MBio"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T09:53:12Z","timestamp":1686477192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14613367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1198743X14613367"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03741.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}